| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Revenue | $9.22B | +14.9% |
| Cost of Revenue | $2.45B | +19.1% |
| Gross Profit | $6.77B | +13.4% |
| R&D Expense | $1.98B | +9.7% |
| SG&A Expense | $442.7M | -34.9% |
| Operating Income | $1.24B | +81.7% |
| Interest Expense | $3.0M | -63.9% |
| Pre-tax Income | $1.60B | +61.5% |
| Income Tax | $461.8M |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.27B | +47.8% |
| Short-term Investments | $634.6M | -39.2% |
| Accounts Receivable | $2.96B | +13.2% |
| Inventory | $113.4M | -2.2% |
| Current Assets | $7.52B | +9.8% |
| Total Assets | $23.58B | +17.9% |
| Current Liabilities | $7.99B | +4.0% |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.72B | +14.1% |
| Investing Cash Flow | -$2.20B | -46.0% |
| Financing Cash Flow | -$778.9M | +42.0% |
| +129.1% |
| Net Income | $1.13B | -56.0% |
| EPS (Basic) | $1.71 | -78.8% |
| EPS (Diluted) | $1.60 | -78.0% |
| Total Liabilities |
| $15.75B |
| +6.3% |
| Stockholders' Equity | $7.82B | +51.4% |